本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Cogent Biosciences, Inc.

10.86
-0.1100-1.00%
盤後10.860.00000.00%17:14 EDT
成交量:173.21萬
成交額:1,856.05萬
市值:15.15億
市盈率:-4.35
高:10.97
開:10.87
低:10.38
收:10.97
資料載入中...
2023/03/14

重要事件披露

8-K - Current report
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/12/12

重要事件披露

8-K - Current report
2022/11/14

重要事件披露

8-K - Current report
2022/11/14

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/09/06

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/08/09

重要事件披露

8-K - Current report
2022/08/09

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/06/21

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/06/17

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/06/16

重要事件披露

8-K/A [Amend] - Current report
2022/06/15

重要事件披露

8-K - Current report
2022/06/14

[補充]招股説明書

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses